About Elligo
Elligo is a Healthcare company based in Austin (United States) founded in 2016. Patient recruitment and site activation services are provided by Elligo. Elligo has raised $176.48 million across 6 funding rounds from investors including Morgan Stanley, Cerner and Syneos Health. The company has 280 employees. Elligo has completed 4 acquisitions, including ClinEdge, Protenium Clinical Research and Root Health. Elligo offers products and services including IntElligo®, Study Marketplace®, and Patient Select. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its competitors include Acurian, Velocity Clinical Research and CenExel; 1 of its 3 listed competitors has raised funding.
Company details
Elligo was founded in 2016 in Austin, United States, and operates as a contract research organization in the health research sector. Core services encompass patient recruitment, site activation, study initiation, and closeout processes. These activities support clinical trials by streamlining site operations and participant enrollment across various studies. The company maintains a focus on efficient research execution within the U.S. geography.
- Headquarters Austin, United States
- Employees 280
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Phone•••• ••••
- Website elligohealthresearch.com
- Social LinkedIn X Facebook
- Total Equity Funding$176.48M (USD)
in 6 rounds
- Latest Funding Round$40M (USD), Debt – Venture
Oct 2023
- InvestorsMorgan Stanley
& 12 more
- Employee Count280
- Investments & AcquisitionsClinEdge
& 3 more
Products & Services of Elligo
Elligo offers a comprehensive portfolio of products and services, including IntElligo®, Study Marketplace®, and Patient Select.
Platform for managing and enabling clinical trials efficiently
Technology for simplifying clinical trial site selection and placement
System for engaging patients in clinical research opportunities
Funding Insights of Elligo
Elligo has successfully raised a total of $176.48M across 6 strategic funding rounds. The most recent funding activity was a Debt – Venture round of $40 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $176.48M
- Total Rounds 6
- Last Round Debt – Venture — $40M
- First Round $16.2M
(Mar 2018)
- Investors Count 13
All 6 funding rounds of Elligo with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2023 | $40M | Debt – Venture | – | – | |
| Sep 2021 | $135M | Series E | – | Ally Bridge Group, Morgan Stanley | |
| Dec 2020 | Series C | – | Cerner | – | |
| May 2019 | $20M | Series C | – | Piper Jaffray | |
| Jan 2019 | $5.27M | Series B | – | – | – |
| Mar 2018 | $16.2M | Series B | – | Hatteras Venture Partners, Noro-Moseley Partners |
13 investors in total: 13 institutional.
Investors in Elligo
Elligo has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include Morgan Stanley, Cerner and Syneos Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Structured debt is provided to life sciences and technology firms. | 2004 | horizontechfinance.com | Farmington, United States | |
Private equity and hedge fund investments in healthcare are managed. | ally-bridge.com | Hong Kong, China | ||
Venture capital and growth equity firm providing investments and resources to entrepreneurs in various sectors. | 1961 | nvp.com | Menlo Park, United States | |
Tech & Life Sciences focused VC firm investing in early stage companies in the US & Europe | hatterasvp.com | Durham, United States | ||
Provider of a PE and VC investing firm | shumwaycapital.com | Greenwich, United States | ||
Tech and Life Sciences focused VC firm investing in the US | noromoseley.com | Atlanta, United States | ||
Venture capital is provided for AI-driven healthcare innovations. | exceleratehealth.com | |||
Wealth management, investment advisory, and financial services are provided. | 1935 | morganstanley.com | New York, United States | |
Online platform for employee health benefits | 1979 | cerner.com | North Kansas City, United States | |
Advisory services for corporate mergers and acquisitions are provided. | 1895 | pipersandler.com | Minneapolis, United States |
Investor details for Elligo
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Elligo
1 people are tracked at Elligo (1 in team); the tracked headcount is 280.
| Name | Role | Group |
|---|---|---|
John Potthoff | Chairperson Of The Board | Team |
Complete people profiles for Elligo
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Elligo
Elligo has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include ClinEdge, Protenium Clinical Research and Root Health.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Patient recruitment and business development services are provided by ClinEdge. | clin-edge.com | Quincy, United States | 2010 | Sep 2021 | •••• | |
AI-based software for clinical trial patient communication is provided. | roothealth.co | Sacramento, United States | 2019 | Jun 2021 | •••• | |
Research organization offering electronic health records and the trusted patient and physician relationship | protenium.com | Hurst, United States | 2010 | Jan 2019 | •••• | |
Clinical trial recruitment service company | epatientfinder.com | Austin, United States | 2013 | May 2018 | •••• |
Complete acquisition details for Elligo
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Elligo
7 dated milestones of Elligo across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Elligo is founded.
- Funding First funding round of $16.2M.
- Acquisition Acquires ePatientFinder.
- Acquisition Acquires Protenium Clinical Research.
- Acquisition Acquires Root Health.
- Acquisition Acquires ClinEdge.
- Funding Latest funding round, Debt – Venture, of $40.0M.
Competitors of Elligo
Elligo has 3 listed competitors in our database, 1 of them funded. They include Acurian, Velocity Clinical Research and CenExel.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| acurian.com | 1998 | Horsham, United States | $27M | Patient enrollment and retention solutions for clinical trials are offered. | ||
| velocityclinical.com | 2017 | Durham, United States | Provider of site management and patient recruitment services | |||
| cenexelresearch.com | 2019 | Salt Lake, United States | 451 | Research site management and patient recruitment services are provided. |
Detailed competitors of Elligo
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Elligo
The website of Elligo (elligohealthresearch.com) receives about 9.1K visits a month and ranks #4,278,976 among all websites worldwide, #5,275 in Biotechnology and Pharmaceuticals.
- Monthly visits9.1K
▲ 148.6% vs previous month
- Unique visitors1.4K
per month
- Global rank#4,278,976
among all websites
- Category rank#5,275
Health · Biotechnology and Pharmaceuticals
- Bounce rate30%
- Pages per visit2.3
- Average visit2 min 03 sec
- DevicesDesktop 49% · Mobile 51%
Websites whose visitors overlap most with Elligo. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
elligocrc.com | elligocrc.com | 100% | #5,670,828 | – |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Elligo (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Elligo
Complete news archive for Elligo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elligo
Elligo was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Elligo is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Elligo is a funded company, having raised a total of $176.48M across 6 funding rounds to date. The company's 1st funding round was a Series B of $16.2M, raised on Mar 2018.
Elligo has 280 employees.
Elligo was founded in 2016 in Austin, United States, and operates as a contract research organization in the health research sector. Core services encompass patient recruitment, site activation, study initiation, and closeout processes. These activities support clinical trials by streamlining site operations and participant enrollment across various studies. The company maintains a focus on efficient research execution within the U.S. geography.
Elligo's top competitors include Velocity Clinical Research, Acurian and CenExel.
Elligo offers IntElligo®, Study Marketplace®, and Patient Select.
Elligo has made 4 acquisitions, including ClinEdge, Protenium Clinical Research, and Root Health.
Elligo has 13 investors. Key investors include Morgan Stanley, Cerner, Syneos Health, Piper Sandler, and Norwest Venture Partners.